| Authors: |
Willocx M; Sciensano, Service of Medicines and Health Products, Brussels, Belgium; KU Leuven, Department of Biosystems, Laboratory of Gene Technology, Leuven, Belgium. Electronic address: Marie.Willocx@sciensano.be., Pirnay JP; Queen Astrid Military Hospital, Laboratory for Molecular and Cellular Technology, Brussels, Belgium. Electronic address: Jean-Paul.Pirnay@mil.be., Merabishvili M; Queen Astrid Military Hospital, Laboratory for Molecular and Cellular Technology, Brussels, Belgium. Electronic address: Maia.Merabishvili@mil.be., Laurent F; Sciensano, Service of Quality of Vaccines and Blood Products, Brussels, Belgium. Electronic address: Flore.Laurent@sciensano.be., Clouet S; Sciensano, Service of Quality of Vaccines and Blood Products, Brussels, Belgium. Electronic address: Sophie.Clouet@sciensano.be., Lavigne R; KU Leuven, Department of Biosystems, Laboratory of Gene Technology, Leuven, Belgium. Electronic address: rob.lavigne@kuleuven.be., Ceyssens PJ; Sciensano, Service of Bacterial Diseases, Brussels, Belgium. Electronic address: Pieter-Jan.Ceyssens@sciensano.be., Vanhee C; Sciensano, Service of Medicines and Health Products, Brussels, Belgium. Electronic address: Celine.Vanhee@sciensano.be. |
